Biosensors: the new wave in cancer diagnosis

The earlier cancer can be detected, the better the chance of a cure. Currently, many cancers are diagnosed only after they have metastasized throughout the body. Effective, accurate methods of cancer detection and clinical diagnosis are urgently needed. Biosensors are devices that are designed to de...

Full description

Saved in:
Bibliographic Details
Published in:Nanotechnology, science and applications science and applications, 2011-01, Vol.4 (default), p.1-10
Main Authors: Bohunicky, Brian, Mousa, Shaker A
Format: Article
Language:English
Subjects:
Anticancer properties
Biomarkers
Biosensors
Cancer
Deoxyribonucleic acid
Diagnosis
DNA
Monitoring
Review
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c513t-2c76ecd805acc1276e25231f19014611e45168c2d36eda59320e096f9ffa02163
cites
container_end_page 10
container_issue default
container_start_page 1
container_title Nanotechnology, science and applications
container_volume 4
creator Bohunicky, Brian
Mousa, Shaker A
description The earlier cancer can be detected, the better the chance of a cure. Currently, many cancers are diagnosed only after they have metastasized throughout the body. Effective, accurate methods of cancer detection and clinical diagnosis are urgently needed. Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents. This review will briefly summarize the current obstacles to early detection of cancer and the expanding use of biosensors as a diagnostic tool, as well as some future applications of biosensor technology.
doi_str_mv 10.2147/NSA.S13465
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_67bd1096b4eb45efb16516000965a7e8</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_67bd1096b4eb45efb16516000965a7e8</doaj_id><sourcerecordid>1540111587</sourcerecordid><originalsourceid>FETCH-LOGICAL-c513t-2c76ecd805acc1276e25231f19014611e45168c2d36eda59320e096f9ffa02163</originalsourceid><addsrcrecordid>eNpdkU9LHTEUxYO0qFg3_QAy4KZIn-bm_3QhqLQqiC5s1yGTufPMY15ik3lKv31jnxX1bpLcnPw4N4eQz0APGQh9dH17cngLXCi5QbYBtJ6ZlvIPr_ZbZLeUBa3FQUjDNskWE9AaYdg2-XoaUsFYUi7fmukOm4iPzaN7wCbExrvoMTd9cPOYSiifyMfBjQV3n9cd8uvH959nF7Orm_PLs5OrmZfApxnzWqHvDZXOe2D1wCTjMEBLQSgAFBKU8aznCnsnW84o0lYN7TA4ykDxHXK55vbJLex9DkuX_9jkgv3XSHluXZ6CH9Eq3fVQH3cCOyFx6EBVeJ21VdJpNJV1vGbdr7ol9h7jlN34Bvr2JoY7O08PlmsDmkIFfHkG5PR7hWWyy1A8jqOLmFbFghQUAKTRVbr_TrpIqxzrV1lWS1PBxZOjg7XK51RKxuHFDFD7lKmtmdp1plW899r-i_R_gvwvKbeY0Q</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2222704348</pqid></control><display><type>article</type><title>Biosensors: the new wave in cancer diagnosis</title><source>Taylor &amp; Francis Open Access</source><source>Publicly Available Content (ProQuest)</source><source>PubMed Central</source><creator>Bohunicky, Brian ; Mousa, Shaker A</creator><creatorcontrib>Bohunicky, Brian ; Mousa, Shaker A</creatorcontrib><description>The earlier cancer can be detected, the better the chance of a cure. Currently, many cancers are diagnosed only after they have metastasized throughout the body. Effective, accurate methods of cancer detection and clinical diagnosis are urgently needed. Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents. This review will briefly summarize the current obstacles to early detection of cancer and the expanding use of biosensors as a diagnostic tool, as well as some future applications of biosensor technology.</description><identifier>ISSN: 1177-8903</identifier><identifier>EISSN: 1177-8903</identifier><identifier>DOI: 10.2147/NSA.S13465</identifier><identifier>PMID: 24198482</identifier><language>eng</language><publisher>New Zealand: Taylor &amp; Francis Ltd</publisher><subject>Anticancer properties ; Biomarkers ; Biosensors ; Cancer ; Deoxyribonucleic acid ; Diagnosis ; DNA ; Monitoring ; Review</subject><ispartof>Nanotechnology, science and applications, 2011-01, Vol.4 (default), p.1-10</ispartof><rights>2011. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2011 Bohunicky and Mousa, publisher and licensee Dove Medical Press Ltd 2011</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c513t-2c76ecd805acc1276e25231f19014611e45168c2d36eda59320e096f9ffa02163</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2222704348/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2222704348?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25731,27901,27902,36989,36990,44566,53766,53768,74869</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24198482$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bohunicky, Brian</creatorcontrib><creatorcontrib>Mousa, Shaker A</creatorcontrib><title>Biosensors: the new wave in cancer diagnosis</title><title>Nanotechnology, science and applications</title><addtitle>Nanotechnol Sci Appl</addtitle><description>The earlier cancer can be detected, the better the chance of a cure. Currently, many cancers are diagnosed only after they have metastasized throughout the body. Effective, accurate methods of cancer detection and clinical diagnosis are urgently needed. Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents. This review will briefly summarize the current obstacles to early detection of cancer and the expanding use of biosensors as a diagnostic tool, as well as some future applications of biosensor technology.</description><subject>Anticancer properties</subject><subject>Biomarkers</subject><subject>Biosensors</subject><subject>Cancer</subject><subject>Deoxyribonucleic acid</subject><subject>Diagnosis</subject><subject>DNA</subject><subject>Monitoring</subject><subject>Review</subject><issn>1177-8903</issn><issn>1177-8903</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpdkU9LHTEUxYO0qFg3_QAy4KZIn-bm_3QhqLQqiC5s1yGTufPMY15ik3lKv31jnxX1bpLcnPw4N4eQz0APGQh9dH17cngLXCi5QbYBtJ6ZlvIPr_ZbZLeUBa3FQUjDNskWE9AaYdg2-XoaUsFYUi7fmukOm4iPzaN7wCbExrvoMTd9cPOYSiifyMfBjQV3n9cd8uvH959nF7Orm_PLs5OrmZfApxnzWqHvDZXOe2D1wCTjMEBLQSgAFBKU8aznCnsnW84o0lYN7TA4ykDxHXK55vbJLex9DkuX_9jkgv3XSHluXZ6CH9Eq3fVQH3cCOyFx6EBVeJ21VdJpNJV1vGbdr7ol9h7jlN34Bvr2JoY7O08PlmsDmkIFfHkG5PR7hWWyy1A8jqOLmFbFghQUAKTRVbr_TrpIqxzrV1lWS1PBxZOjg7XK51RKxuHFDFD7lKmtmdp1plW899r-i_R_gvwvKbeY0Q</recordid><startdate>20110101</startdate><enddate>20110101</enddate><creator>Bohunicky, Brian</creator><creator>Mousa, Shaker A</creator><general>Taylor &amp; Francis Ltd</general><general>Dove Medical Press</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7XB</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>F28</scope><scope>FR3</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>M2O</scope><scope>MBDVC</scope><scope>P5Z</scope><scope>P62</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20110101</creationdate><title>Biosensors: the new wave in cancer diagnosis</title><author>Bohunicky, Brian ; Mousa, Shaker A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c513t-2c76ecd805acc1276e25231f19014611e45168c2d36eda59320e096f9ffa02163</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Anticancer properties</topic><topic>Biomarkers</topic><topic>Biosensors</topic><topic>Cancer</topic><topic>Deoxyribonucleic acid</topic><topic>Diagnosis</topic><topic>DNA</topic><topic>Monitoring</topic><topic>Review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bohunicky, Brian</creatorcontrib><creatorcontrib>Mousa, Shaker A</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>ANTE: Abstracts in New Technology &amp; Engineering</collection><collection>Engineering Research Database</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Nanotechnology, science and applications</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bohunicky, Brian</au><au>Mousa, Shaker A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Biosensors: the new wave in cancer diagnosis</atitle><jtitle>Nanotechnology, science and applications</jtitle><addtitle>Nanotechnol Sci Appl</addtitle><date>2011-01-01</date><risdate>2011</risdate><volume>4</volume><issue>default</issue><spage>1</spage><epage>10</epage><pages>1-10</pages><issn>1177-8903</issn><eissn>1177-8903</eissn><abstract>The earlier cancer can be detected, the better the chance of a cure. Currently, many cancers are diagnosed only after they have metastasized throughout the body. Effective, accurate methods of cancer detection and clinical diagnosis are urgently needed. Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents. This review will briefly summarize the current obstacles to early detection of cancer and the expanding use of biosensors as a diagnostic tool, as well as some future applications of biosensor technology.</abstract><cop>New Zealand</cop><pub>Taylor &amp; Francis Ltd</pub><pmid>24198482</pmid><doi>10.2147/NSA.S13465</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1177-8903
ispartof Nanotechnology, science and applications, 2011-01, Vol.4 (default), p.1-10
issn 1177-8903
1177-8903
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_67bd1096b4eb45efb16516000965a7e8
source Taylor & Francis Open Access; Publicly Available Content (ProQuest); PubMed Central
subjects Anticancer properties
Biomarkers
Biosensors
Cancer
Deoxyribonucleic acid
Diagnosis
DNA
Monitoring
Review
title Biosensors: the new wave in cancer diagnosis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T21%3A20%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Biosensors:%20the%20new%20wave%20in%20cancer%20diagnosis&rft.jtitle=Nanotechnology,%20science%20and%20applications&rft.au=Bohunicky,%20Brian&rft.date=2011-01-01&rft.volume=4&rft.issue=default&rft.spage=1&rft.epage=10&rft.pages=1-10&rft.issn=1177-8903&rft.eissn=1177-8903&rft_id=info:doi/10.2147/NSA.S13465&rft_dat=%3Cproquest_doaj_%3E1540111587%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c513t-2c76ecd805acc1276e25231f19014611e45168c2d36eda59320e096f9ffa02163%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2222704348&rft_id=info:pmid/24198482&rfr_iscdi=true